top of page
Laboratory

Changing the Future for Your Health

Our mission is to revolutionize early cancer detection using Generative AI for biomedical data analysis. 

AIMedExpert_Logo_Icon.png

At AIMedExpert, a brand of Artificial Intelligence Expert Company (AIE), we are committed to transforming cancer care through groundbreaking AI-driven early detection. Our innovative non-invasive tests can identify 32 types of cancer with over 99-100% accuracy, offering a profound impact by alleviating fear, pain, and financial burdens for patients. Since 2008, our collaboration with the renowned MD Anderson Cancer Center has yielded remarkable breakthroughs in oncology diagnostics. Achieving near-perfect accuracy, our innovations have secured international patents, setting new benchmarks in the industry.

AFloares_edited.jpg

Alexandru Floares, MD,PhD

CEO and Founder

Alexandru Floares, MD, PhD, founder and CEO of Artificial Intelligence Expert, is a leader in AI-powered medical diagnostics and therapy personalization. Since founding the AI Department at the Oncology Institute of Cluj-Napoca in 2000 and launching SAIA in 2004, he has set new industry standards, particularly in oncology. His work includes developing the first intelligent system for extracting mathematical models from biomedical data and leading significant research projects. Dr. Floares has presented his findings at prestigious institutions such as the NIH and the Vatican, published extensively, and received numerous awards. Since 2008, his collaboration with MD Anderson Cancer Center has led to revolutionary AI-enabled diagnostics for various cancers, achieving up to 100% accuracy and resulting in an international patent application.

Our team is led by our CEO, recognized as one of the 500 geniuses of the 21st century, with vast expertise in AI and medicine. We also have young, ambitious bioinformaticians and researchers specialized in multidisciplinary fields. Their combined talents drive our innovative approach to early cancer detection and revolutionizing research through the implementation of AI tools for researchers.

Our Team

Screenshot 2024-06-10 at 11.28_edited.jp

Carmen Floares

CoFounder & Chief Medical Officer

Screenshot 2024-03-12 at 09.44.31.png

Catalin Marginean

Account & Financial Manager

image.jpg

Adrian Zety

Chief Technology Officer

Lampros.jpeg

Lampros Androutsos

Product Manager

Screenshot 2024-06-10 at 11.20.47.png

Larisa Petcu

Project Manager

Advisory Board

Our Advisory Board includes world-renowned cancer research and computing professors, as well as experienced leaders in business development and marketing. Their combined expertise drives our mission to revolutionize early cancer detection with advanced AI technologies.

1709900133.jpg

George Calin,

MD-PhD

Co-Director of The RNA Interference and Non-coding RNA Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA

DrFlorinManolache.jpeg

Florin Manolache, PhD

Director of Scientific Computing for MCS at Carnegie Mellon University

Antonio Ornelas-Soares.jpeg

Antonio Ornelas-Soares, PhD

CEO of LUMABS

1655912007909.jpeg

Ada Brzezicki,

MD, MBA

Senior Business Development Manager at Partner International

Mihaela-Rus-_-2_edited.jpg

Mihaela Rus

CEO Vitrina Advertising

bottom of page